These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21613813)

  • 1. Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study.
    Wehr E; Pieber TR; Obermayer-Pietsch B
    J Endocrinol Invest; 2011 Nov; 34(10):757-63. PubMed ID: 21613813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
    Karadağ C; Yoldemir T; Yavuz DG
    J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
    Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
    Ardabili HR; Gargari BP; Farzadi L
    Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.
    Seyyed Abootorabi M; Ayremlou P; Behroozi-Lak T; Nourisaeidlou S
    Gynecol Endocrinol; 2018 Jun; 34(6):489-494. PubMed ID: 29271278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
    Menichini D; Facchinetti F
    Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial.
    Raja-Khan N; Shah J; Stetter CM; Lott ME; Kunselman AR; Dodson WC; Legro RS
    Fertil Steril; 2014 Jun; 101(6):1740-6. PubMed ID: 24636395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial.
    Al-Bayyari N; Al-Domi H; Zayed F; Hailat R; Eaton A
    Clin Nutr; 2021 Mar; 40(3):870-878. PubMed ID: 33010974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 11. Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial.
    Irani M; Seifer DB; Grazi RV; Julka N; Bhatt D; Kalgi B; Irani S; Tal O; Lambert-Messerlian G; Tal R
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4307-14. PubMed ID: 26485217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
    Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial.
    Trummer C; Schwetz V; Kollmann M; Wölfler M; Münzker J; Pieber TR; Pilz S; Heijboer AC; Obermayer-Pietsch B; Lerchbaum E
    Eur J Nutr; 2019 Aug; 58(5):2019-2028. PubMed ID: 29946756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA; Shin SY; Yoon BK; Choi D
    Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
    Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
    J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D Decreases Serum VEGF Correlating with Clinical Improvement in Vitamin D-Deficient Women with PCOS: A Randomized Placebo-Controlled Trial.
    Irani M; Seifer DB; Grazi RV; Irani S; Rosenwaks Z; Tal R
    Nutrients; 2017 Mar; 9(4):. PubMed ID: 28350328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome.
    Nestler JE; Reilly ER; Cheang KI; Bachmann LM; Downs RW
    Trans Am Clin Climatol Assoc; 2012; 123():209-19; discussion 219-20. PubMed ID: 23303986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of calcium and vitamin D supplementation on the clinical, hormonal, and metabolic profile in non-obese women with polycystic ovary syndrome.
    Sert ZS; Yılmaz SA; Seçilmiş Ö; Abuşoğlu S; Ünlü A; Çelik Ç
    Ir J Med Sci; 2022 Dec; 191(6):2657-2662. PubMed ID: 35088227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome.
    Selimoglu H; Duran C; Kiyici S; Ersoy C; Guclu M; Ozkaya G; Tuncel E; Erturk E; Imamoglu S
    J Endocrinol Invest; 2010 Apr; 33(4):234-8. PubMed ID: 19820295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome.
    Pal L; Berry A; Coraluzzi L; Kustan E; Danton C; Shaw J; Taylor H
    Gynecol Endocrinol; 2012 Dec; 28(12):965-8. PubMed ID: 22780885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.